Extract
AVANT to Pursue Development of Avian Flu Vaccine.
NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that it has formed a research team to focus on development of an avian flu vaccine utilizing in part AVANT's proprietary bacterial vectoring technologies and Vitr...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
When the Going Gets Tough | time to hit big flower shows | Excellent A Good Fall. | Benjamin Moore Launches E-Commerce Selling Its Paints & Supplies Online. | Décret n° 2002-720 du 2 mai 2002 relatif aux règles prudentielles applicables aux mutuelles et unions pratiquant des opérations d assurance et de capita... | sentencia nº 4199 de consiglio di stato august 26 2009 | sentenza nº 7353 de consiglio di stato november 24 2009 | dispositivo nº 396 de consiglio di stato, june 07, 2010
